logologo
QuantliQuantli

Elutia Inc

ELUT

NASDAQ

Biotechnology

$0.94

USD

+0.08 (+9.38%)

At close: Aug 14, 2026, 4:00 PM EDT

Market Cap $37.54M

Volume 67.0K

Price (USD)
Price (USD)

About Elutia Inc

The company is headquartered in Silver Spring, Maryland and currently employs 25 full-time employees. The company went IPO on 2020-10-08.

CEO

Dr. C. Randal Mills

HQ

Silver Spring, MARYLAND, US

Founded

2020

Employees

25

Quantli Score

8.4

Outperform

Fin. Health

8.1

Profitability

7.6

Growth

9.0

Cash-Flow Q.

8.8

Key Metrics

6 metrics our research team weighs before forming a view on ELUT.

Based on Quantli research · SEC filings · as of Q1 2026

METRIC

VALUE

CHANGE

TREND (3Y)

Revenue Growth (TTM)

1.6%

Gross Margin (TTM)

54.0%

+7.6 pp

Operating Margin (TTM)

-175.3%

+27.8 pp

Net Margin (TTM)

312.1%

+565.8 pp

ROE (TTM)

221.3%

Free Cash Flow (TTM)

$-45.82M

Financial Snapshot

Full Financials

Revenue

$15.97M

+1.6%

YoY

Gross Margin

54%

TTM

+16.4%

YoY

Net Income

$49.84M

+225.0%

YoY

Operating Cash Flow

$-43.76M

-51.4%

YoY

Key Statistics

Open

$0.88

Previous Close

$0.86

Day Range

$0.86 - $0.95

52 Week Range

$0.50 - $2.50

Volume

67.0K

Average Volume (10 Days)

40.0K

Dividend Yield

Valuation Measurement

Market Cap

$37.54M

P/E Ratio (TTM)

0.75

P/S Ratio (TTM)

2.35

Price / Book

1.67

Financial Highlights

Profit Margin

312.1%

Return on Assets

90.3%

Return on Equity

221.3%

Revenue (TTM)

$15.97M

Net Income (TTM)

$49.84M

Diluted EPS (TTM)

$0.87

Total Cash (MRQ)

$28.49M

Levered FCF (TTM)

$-45.82M

Turn research into action

Knowing a stock is strong is the start. Knowing how to invest in it when you spot good research is good returns.

Swing Strategy

Buy support, sell on recovery.

Best for:

Risk-tolerant

Trend Following

Enter on trend. Cut losses fast.

Best for:

Active traders

Position Strategy

Ride market cycles. Patient hold.

Best for:

Patient investors

Go deeper on ELUT

Similar Stocks

NXTC

NextCure Inc

$8.21

-0.8%

TVGN

Tevogen Bio Holdings Inc

$6.87

+4.6%

MGX

Metagenomi Therapeutics Inc

$1.23

0.0%

CRVO

CervoMed Inc

$2.73

-6.8%

KPTI

Karyopharm Therapeutics Inc

$2.02

+1.5%

ALGS

Aligos Therapeutics Inc

$6.89

+1.8%

MCRB

Seres Therapeutics Inc

$4.54

+1.3%

Earnings Calendar

Next Earnings

Estimated Q3 Release

Nov 04

Est. EPS

Adjusted consensus estimate

-$0.13